SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SNRS- Sunrise Technologies -- Ignore unavailable to you. Want to Upgrade?


To: majormember who wrote (1873)12/12/1998 1:28:00 PM
From: admr  Read Replies (2) | Respond to of 4140
 
PMA annoucement I'm told is now for Tuesday. Also heard that S&P will have follow up article this week. Also I seen posted the belief that Business Week will publish S&P Stock of the Week story.



To: majormember who wrote (1873)12/12/1998 11:20:00 PM
From: MJB8743  Read Replies (2) | Respond to of 4140
 
Skane,

<< Since SNRS is not approved (yet), and the storyline tag states
"benifits and risks" I assume they are referring to existing
surgary, ie: PRK/LASIK. Unless the story is about the "not yet
approved" SNRS specific LTK procedure, don't get too exited. >>

If the article accurately shows the procedures (cutting flaps, burning troughs around the cornea, etc), that exist now, then Sunrise will surely stand out when it makes its debut. Any mention of SNRS would be gravy, but I don't expect it. I guess I just want the public to be aware of the risks and nastiness of PRK/LASIK. Sort of like appreciating a good home-cooked meal after experiencing starvation.

Mickie